Yuki Iijima Yosuke Hirotsu Kenji Amemiya Seishi Higashi Yoshihiro Miyashita Masao Omata
10.1016/j.rmcr.2017.05.015
Respir Med Case Rep
2017 Jun 5;22:31-33.
circulating tumor dna immune checkpoint therapy lung cancer nivolumab pd-1
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28649487/
Case Reports
PMC5470530
28649487
Rapid decrease of circulating tumor DNA predicted the treatment effect of nivolumab in a lung cancer patient within only 5 days
2017